Basket Trial Evaluates Oral Ponatinib for Solid Tumors With Genomic Alterations
A phase 2 basket trial found oral ponatinib did not meet its primary endpoint in solid tumors with FGFR alterations, ...
A phase 2 basket trial found oral ponatinib did not meet its primary endpoint in solid tumors with FGFR alterations, ...
In a groundbreaking development poised to redefine the treatment landscape for mesothelioma, researchers have unveiled promising results from an early-phase ...
FAETH THERAPEUTICS AND THE GOG FOUNDATION, INC. LAUNCH FIRST PHASE 2 COMBINATION TRIAL FOR SAPANISERTIB-SERABELISIB IN PATIENTS WITH ENDOMETRIAL CANCER ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.